RecruitingNot ApplicableNCT07418125
Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIA
Sponsor
Institute of Oncology Ljubljana
Enrollment
130 participants
Start Date
Feb 7, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
CTCs, CTC clusters, and ctDNA may predict treatment response and survival in high-risk breast cancer, including IBC.
Eligibility
Sex: FEMALEMin Age: 18 Years
Inclusion Criteria3
- Patients with inflammatory breast cancer, regardless of cancer subtype (stage IIID)
- Patients with non-inflammatory breast cancer: triple-negative and HER2+ subtypes, from stage IIB to IIIA-C
- Adequate health status for neoadjuvant systemic treatment
Exclusion Criteria7
- Inflammatory breast cancer stage IV
- Luminal A, luminal B subtypes of non-inflammatory breast cancer
- Stages I-IIA breast cancer
- Inability to understand or communicate in Slovenian
- Inability to follow protocol instructions
- Inappropriate health status for chemotherapy treatment
- Primary treatment with surgery
Interventions
DIAGNOSTIC_TESTLiquid biopsy
Additional liquid biopsy to monitor disease
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07418125
Related Trials
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
NCT0661828763 locations
Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
NCT069260753 locations
Cardiac Outcomes With Near-Complete Estrogen Deprivation
NCT053096553 locations
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
NCT041190243 locations
EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
NCT074780161 location